Status: current, Defined. Date: 31-Mar 2017. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3057221000168111 | Strensiq (asfotase alfa 40 mg / 1 mL) injection, 12 x 1 mL vials (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
3057231000168114 | Strensiq 40 mg/mL injection, 12 x 1 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Strensiq 40 mg/mL injection, 12 x 1 mL vials | Is a | trade product pack | true | Inferred relationship | Some | ||
Strensiq 40 mg/mL injection, 12 x 1 mL vials | Is a | asfotase alfa 40 mg/mL injection, 12 x 1 mL vials | true | Inferred relationship | Some | ||
Strensiq 40 mg/mL injection, 12 x 1 mL vials | has TPUU | Strensiq 40 mg/mL injection, vial | true | Inferred relationship | Some | 1 | |
Strensiq 40 mg/mL injection, 12 x 1 mL vials | has TP | Strensiq | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Strensiq (asfotase alfa 40 mg / 1 mL) injection, 12 x 1 mL vials (containered trade product pack) | Is a | True | Strensiq 40 mg/mL injection, 12 x 1 mL vials | Inferred relationship | Some |
Reference Sets
Trade product pack reference set